Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care

Ataraxis AI Raises $20.4 Million in Series A Led by AIX Ventures

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

#NYCtech Week in Review: 1/5/25 – 1/11/25

VP of Sales

Ataraxis AI is an AI precision medicine company focused on transforming cancer treatment through innovative AI-native tools. They are seeking a VP of Sales to build and refine their sales strategy for Ataraxis Breast, recruit and mentor a high-performing sales team, and represent the company in the oncology space.

Sign up with Google

Sign in with Google